Psychodynamic Psychotherapy for PTSD
(RCT of TFPP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy called Trauma-Focused Psychodynamic Psychotherapy (TFPP) for veterans with PTSD who haven't improved with standard treatments at the VA. TFPP is a specialized talk therapy that addresses trauma symptoms. The trial compares TFPP to regular care at the VA to determine which is more effective. Veterans with moderate PTSD symptoms, despite trying other treatments like Cognitive Processing Therapy (CPT) or Prolonged Exposure (PE), might be suitable candidates for this trial. As an unphased trial, it offers veterans a unique opportunity to explore a new therapy option that could potentially improve their PTSD symptoms.
Will I have to stop taking my current medications?
The trial requires participants to be stable on their psychiatric medications for at least 2 months before joining, so you should not stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Trauma-Focused Psychodynamic Psychotherapy (TFPP) is generally well-received by patients. One study found that 86% of participants completed the therapy, indicating its manageability for most people. This therapy addresses current PTSD symptoms rather than revisiting past traumatic events, which may make it easier for some compared to treatments that directly explore past trauma. Although TFPP has not been studied as extensively as treatments like Prolonged Exposure or Cognitive Processing Therapy, early results are promising regarding safety and patient tolerance.12345
Why are researchers excited about this trial?
Researchers are excited about Trauma-Focused Psychodynamic Psychotherapy (TFPP) for PTSD because it offers a distinct approach compared to the standard cognitive-behavioral therapies. TFPP specifically targets trauma symptoms through a psychodynamic method, which delves into the underlying emotional conflicts and past experiences contributing to PTSD. This approach can be particularly beneficial for individuals who haven't fully responded to more conventional treatments like Cognitive Processing Therapy (CPT) or Prolonged Exposure (PE). By focusing on the emotional and psychological roots of trauma, TFPP has the potential to offer deeper, more sustained healing for people with PTSD.
What evidence suggests that Trauma-Focused Psychodynamic Psychotherapy might be an effective treatment for PTSD?
This trial will compare Trauma-Focused Psychodynamic Psychotherapy (TFPP) with Treatment as Usual (TAU) for PTSD. Research has shown that TFPP can help reduce PTSD symptoms. One study found that TFPP significantly improved symptoms of PTSD, anxiety, and depression. Another study demonstrated that long-term psychodynamic therapy positively affected PTSD symptoms. Overall, TFPP appears promising for individuals who haven't found relief with other treatments.26789
Who Is on the Research Team?
Barbara L Milrod, MD
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for Veterans with moderate PTSD (CAPS score >40) who haven't improved after standard VA treatments. They must have stable psychiatric meds for 2 months and a history of not responding well to certain PTSD therapies. It's not for those with severe suicidality, psychosis, bipolar disorder, substance issues that affect participation, or unstable medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Trauma-Focused Psychodynamic Psychotherapy (TFPP) or Treatment as Usual (TAU) for PTSD
Follow-up
Participants are monitored for changes in PTSD symptoms and other psychological measures
What Are the Treatments Tested in This Trial?
Interventions
- TAU
- Trauma-Focused Psychodynamic Psychotherapy (TFPP)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
Weill Medical College of Cornell University
Lead Sponsor
International Psychoanalytic Association (IPA)
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator
Weill Medical College Clinical Science Translation Center
Collaborator
American Psychoanalytic Association (APsA)
Collaborator
International Psychoanalytic Association
Collaborator
VA New York Harbor Healthcare System
Collaborator
CTSC
Collaborator
American Psychoanalytic Association Fund for Psychoanalytic Research
Collaborator